Heritage Valley Medical Group
Beaver, Pennsylvania 15009
2 studies enrolling now · 11 studies all time
What they study most
Atherosclerosis, Cardiovascular Disease, Cardiovascular Diseases, Carotid Stenosis, Cerebral Infarction, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Hypertension, Kidney Disease, Chronic, Myocardial Infarction, Obesity, Obesity and Diabetes Mellitus, Type 2
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease — Running, not enrolling
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) — Completed
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. — Completed
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus — Completed
- A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis — Completed
- Carotid Revascularization Endarterectomy Versus Stenting Trial — Completed
- Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes — Completed